(Q35028109)

5 August 2017

title

Dual pathway for angiotensin II formation in human internal mammary arteries (English)

1 reference

5 August 2017

8

Ganten D

1 reference

5 August 2017

Voors AA

1

1 reference

5 August 2017

Pinto YM

2

1 reference

5 August 2017

Buikema H

3

1 reference

5 August 2017

Urata H

4

1 reference

5 August 2017

Oosterga M

5

1 reference

5 August 2017

Rooks G

6

1 reference

5 August 2017

Grandjean JG

7

1 reference

5 August 2017

van Gilst WH

9

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 1998

1 reference

British Journal of Pharmacology

5 August 2017

published in

1 reference

5 August 2017

volume

125

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

1028-1032

1 reference

Direct evidence for the presence of a different converting enzyme in the hamster cheek pouch

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702150

Angiotensins and the failing heart. Enhanced positive inotropic response to angiotensin I in cardiomyopathic hamster heart in the presence of captopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702150

The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702150

7 January 2021

Electromechanical effects of angiotensin in human atrial tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702150

7 January 2021

Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702150

7 January 2021

Measurement of angiotensin I converting enzyme inhibition in the heart

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702150

7 January 2021

Vasoconstrictor action of angiotensin I-convertase and the synthetic substrate (Pro11,D-Ala12)-angiotensin I

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702150

7 January 2021

Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702150

7 January 2021

Different distribution of two types of angiotensin II-generating enzymes in the aortic wall

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702150

7 January 2021

Marked species-difference in the vascular angiotensin II-forming pathways: humans versus rodents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702150

7 January 2021

Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702150

7 January 2021

Angiotensin-Converting Enzyme and the Regulation of Vasoactive Peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702150

7 January 2021

Beneficial effects of a serine protease inhibitor in peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702150

7 January 2021

Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702150

7 January 2021

Angiotensin II-forming pathways in normal and failing human hearts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702150

7 January 2021

Different activation of the endothelial L-arginine and cyclooxygenase pathway in the human internal mammary artery and saphenous vein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702150

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0702150

1 reference

5 August 2017

1 reference

5 August 2017

1 reference